Add-Aspirin Trial

Add-Aspirin Trial Add-Asprin trial logo

Add-Aspirin is a large clinical trial taking place in the UK, Republic of Ireland and India. The trial aims to involve 11,000 participants to help find out whether using regular aspirin after treatment of early stage cancer can help stop the cancer coming back (3). Add-Aspirin is open to patients with a number of different cancers including oesophageal cancer and stomach cancer.

There is already data from smaller studies supporting the theory that aspirin can be both safe and useful in the treatment of cancer (4). Add-Aspirin is a much larger international trial designed to further investigate the potential benefits of aspirin. Participants that agree to take part in the study will be randomly chosen to either take daily small doses of aspirin, larger doses of aspirin, or a tablet with no active drug ingredient (called a placebo pill). Neither the patient nor the doctor will know which treatment is being given which helps to make the trial results more reliable.

As a low-cost medicine that is widely available, aspirin could have a huge impact on cancer treatment worldwide. If you are interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.

3. Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, et al. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemp Clin Trials. 512016. p. 56-64

4. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23(6):1403-15.

Latest

We really do have the most unbelievable supporters

We absolutely love to be share good news and in the last few weeks we have had such a great buzz in our team because of our wonderful fundraisers and the extraordinary lengths they have gone to in support of HCUK.
The Royal Parks Half 2022

The Royal Parks Half presented by Royal Bank of Canada is the only event of it's kind. Starting in Hyde Park, it provides a unique opportunity to support the life changing work of Heartburn Cancer UK whilst participating in a truly iconic experience.
The HCUK Virtual Santa Dash

Grab some family, friends, children and even the dog and run, walk, cycle or scoot 5k. Wear a Santa hat if you like (or a full costume if it takes your fancy) and support our work in raising awareness of the early signs of oesophageal cancer.
Early diagnosis - Saving lives

We are fundraising to establish a longer term early diagnostic service using the Cytosponge, bringing the opportunity for early diagnosis to the communities that need it most, improving outcomes and saving lives.

Persistent heartburn

Persistent heartburn. Do not ignore persistent heartburn. If it lasts for more than 3 weeks consult your GP. Persistent heartburn can be a symptom of oesophageal cancer.
Oesophageal cancer

Oesophageal cancer is when abnormal cells in the food pipe grow in an uncontrolled way. Oesophageal cancer can occur in the lower or upper part of the oesophagus.
Barrett's oesophagus

Barrett’s oesophagus, often known as just Barrett’s, is a condition that affects the lining of the oesophagus. Cancer of the oesophagus is more likely in people who have Barrett’s.
Danny's Story

Danny lost his short battle with oesophageal cancer on the 21st February 2021. His family want to share his story to encourage others to seek medical advice if they have any health concerns.
Newsletters

Please take a look at our current and historic newsletters
Basingstoke Support Group

Welcome to the homepage of the Barrett's, Stomach and Oesophageal Cancer support group based in Basingstoke, Hampshire.
Giving in memory

Giving in memory of someone special can be a positive way to celebrate their life, as well as being of great comfort to friends and family. Our tribute funds create a lasting memorial to your loved one and are completely personal to you.
LINACRE Trial

The Oxford Clinical Trials Unit are applying for funding for an exciting new clinical trial for patients with Barrett’s Oesophagus. Recruited patients will be randomly selected to either continue with life long medication or have a device, called a LINX, fitted at the base of the oesophagus to reduce the symptoms associated with Barrett's.
Buy your greetings cards

Browse a selection of over 1300 greetings cards from our partner, Making a Difference Cards, and raise funds for Heartburn Cancer UK whilst letting your loved ones know that you care.
Jennifer's Story

Jennifer was shocked when she was diagnosed with Barrett's oesophagus and silent reflux but we're delighted to hear how she's changed her lifestyle for the positive.